prof. Filip Van den Bosch
- Work address
-
C. Heymanslaan 10, ingang 12 - verdieping 6
9000 Gent - Filip.VanDenBosch@UGent.be
- ORCID iD
-
0000-0002-3561-5932
Show
Sort by
-
Ixekizumab Improves Functioning and Health in the Treatment of Radiographic Axial Spondyloarthritis: Week 52 Results from 2 Pivotal Studies
-
- Journal Article
- A1
- open access
Continuing versus withdrawing ixekizumab treatment in patients with axial spondyloarthritis who achieved remission : efficacy and safety results from a placebo-controlled, randomised withdrawal study (COAST-Y)
-
- Journal Article
- A1
- open access
Efficacy of a tight-control and treat-to-target strategy in axial spondyloarthritis : results of the open-label, pragmatic, cluster-randomised TICOSPA trial
-
The value of magnetic resonance imaging for assessing disease extent and prediction of relapse in early peripheral spondyloarthritis
-
TNFi-induced sustained clinical remission in peripheral spondyloarthritis patients cannot be maintained with a step-down strategy based on methotrexate
(2021) RHEUMATOLOGY. -
- Journal Article
- A1
- open access
Switching between Janus kinase inhibitor upadacitinib and adalimumab following insufficient response : efficacy and safety in patients with rheumatoid arthritis
-
- Journal Article
- A1
- open access
Upadacitinib for psoriatic arthritis refractory to biologics : SELECT-PsA 2
-
MRI-based synthetic CT in the detection of structural lesions in patients with suspected sacroiliitis : comparison with MRI
-
Achievement of remission endpoints with secukinumab over 3 years in active ankylosing spondylitis : pooled analysis of two phase 3 studies
-
- Journal Article
- A1
- open access
Points to consider for the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors : a consensus statement